NCT01924273|CompletedPhase 1DMC
Loading search results
Sponsor study identifier
interventional
7
1 country
1
Study Start
June 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 3, 2017
Actual (reported)Study Completion
July 3, 2017
Actual (reported)Port wine stains Birthmark are congenital, progressive vascular malformations of the skin that occur in approximately 0.7% of newborns. Approximately 1.5 million individuals in the United States and 32 million people worldwide have Port wine stains birthmarks. Two-thirds of these malformations occur on the face. Personality development of virtually all patients is adversely affected as a result of the negative reaction of others to a "marked" person. Detailed studies have documented lower self-esteem and difficulties with interpersonal interactions in Port wine stains patients. Port wine stains are initially flat and red, but with time, they tend to darken to purple and become thickened as vascular nodules develop. This thickening occurs in approximately two-thirds of lesions and further disfigures the facial features of many patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 3, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2013
Date type not reportedThis date has not been verified as actual or estimated.
July 17, 2013
Actual (reported)August 16, 2013
Actual (reported)July 3, 2017
Actual (reported)July 3, 2017
Actual (reported)Port wine stain blanching
The outcome measure will be PWS blanching as assessed by Diffuse Reflectance Imaging/Laser Speckle Imaging/Spatial Frequency Domain Imaging.
up to 12 weeks
Combined Photodynamic/Pulsed Dye Laser Therapy/Talaporfin sodium
Combined Photodynamic/Pulsed Dye Laser Therapy/Talaporfin sodium
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Beckman Laser Institute
Irvine, California, 92612, United States
Kristen Kelly, MD
Beckman Laser Institute
7 participants (actual enrollment reported by the registry).
First Submitted
July 17, 2013
First Posted
August 16, 2013
Study Start
June 2013
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
July 3, 2017
Actual (reported)Study Completion
July 3, 2017
Actual (reported)Last Updated
November 1, 2022
Record last verified: 2022-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: